| Tender Details | ||||||||
|
||||||||
| Deadline * | ||||||||
|
||||||||
| Client Address | ||||||||
|
||||||||
| More Information | ||||||||
| Know More | ||||||||
Similar Tenders
- Ref No: 9869302
- Location: France
Supply Of Safety Shoes For The Meuse Department
- Deadline: 14 Nov 2025
- Ref No: 8259327
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1
- Deadline: 10 May 2026
- Ref No: 8260726
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg
- Deadline: 10 May 2026
- Ref No: 5304541
- Location: Netherlands
Career Paths Construction Technology And Green
- Deadline: 30 Apr 2026
- Ref No: 5308958
- Location: Sweden
Dynamic Purchasing System Dis Rental Of New And Used Agricultural Machinery And Agricultural Implements
- Deadline: 23 Apr 2034
- Ref No: 5301821
- Location: Bulgaria
Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad
- Deadline: 27 May 2027
- Ref No: 5396790
- Location: Germany
Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L
- Deadline: 27 Apr 2026
- Ref No: 4608627
- Location: Canada
Concussion And Vestibular Physiotherapy Services
- Deadline: 18 Mar 2026
- Ref No: 4640403
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr
- Deadline: 28 Feb 2026
- Ref No: 4640423
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr
- Deadline: 28 Feb 2026
- Ref No: 4640900
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr
- Deadline: 28 Feb 2026
